Your browser doesn't support javascript.
loading
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.
De Angelis, Roberta; Minicozzi, Pamela; Sant, Milena; Dal Maso, Luigino; Brewster, David H; Osca-Gelis, Gemma; Visser, Otto; Maynadié, Marc; Marcos-Gragera, Rafael; Troussard, Xavier; Agius, Dominic; Roazzi, Paolo; Meneghini, Elisabetta; Monnereau, Alain.
Afiliación
  • De Angelis R; Centro Nazionale di Epidemiologia, Sorveglianza e promozione della Salute (CNESPS), Istituto Superiore di Sanità (ISS), Rome, Italy. Electronic address: roberta.deangelis@iss.it.
  • Minicozzi P; Department of Preventive and Predictive Medicine, Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Sant M; Department of Preventive and Predictive Medicine, Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Dal Maso L; Epidemiology and Biostatistics Unit, CRO Aviano National Cancer Institute IRCCS, Aviano, Italy.
  • Brewster DH; Scottish Cancer Registry, Public Health & Intelligence, NHS National Services Scotland, Edinburgh EH12 9EB, UK.
  • Osca-Gelis G; Epidemiology Unit and Girona Cancer Registry (Oncology Coordination Plan), Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute, Girona, Spain; Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Giron
  • Visser O; Department of registration, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
  • Maynadié M; Registre des Hémopathies Malignes de Côte d'Or, EA 4184, Université de Bourgogne, Service d'Hématologie Biologique, CHU de Dijon, France.
  • Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry (Oncology Coordination Plan), Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute, Girona, Spain.
  • Troussard X; Registre Régional des Hémopathies Malignes de Basse Normandie, CHU Côte de Nacre, France.
  • Agius D; Malta National Cancer Registry, Malta.
  • Roazzi P; Servizio Elaborazione Dati (SIDBAE), Istituto Superiore di Sanità (ISS), Roma, Italy.
  • Meneghini E; Department of Preventive and Predictive Medicine, Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Monnereau A; Registre des hémopathies malignes de la Gironde, Institut Bergonié, Bordeaux, France 12 Centre Inserm U897, CIC 1401, Bordeaux, France.
Eur J Cancer ; 51(15): 2254-2268, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26421827

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur J Cancer Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur J Cancer Año: 2015 Tipo del documento: Article